Comparison of Zinc Oxide Eugenol to Ferric Sulphate Pulpotomy in Primary Teeth

Sponsor
King Abdullah University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05792748
Collaborator
Jordan University of Science and Technology (Other)
65
1
2
14.9
4.4

Study Details

Study Description

Brief Summary

In this prospective randomized, single blinded; split-mouth clinical trial the aim was to evaluate clinical and radiographic effects of placement of reinforced zinc oxide eugenol (ZOE) base directly over the amputated pulp stumps in pulpotomized primary molars, and to compare this technique to ferric sulphate (FS) in pulpotomized primary teeth. Included were 65 children using a split-mouth design, (130 teeth). All teeth were then restored with prefabricated stainless steel crowns (SSC). Patients were recalled for clinical and radiographical evaluation after 3, 6, 12 and 24 months. Two experienced and calibrated pediatric dentists who were not involved in the investigation blindly assessed the radiographs.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pulp hemostasis with a dry cotton pellet
  • Procedure: Pulp hemostasis with a wet cotton pellet impregnated with FS
  • Procedure: Stainless steel crown
N/A

Detailed Description

Purpose:

The purpose of this study was to evaluate the clinical and radiographic effects of placement of reinforced zinc oxide eugenol (ZOE) base directly over the amputated pulp stumps in pulpotomized primary molars, and to compare the effects of this technique to ferric sulphate (FS) agent in pulpotomized primary teeth.

Methods:

A sample of 65 children with bilateral deep carious mandibular primary molars who attended the pediatric dental clinics, at Jordan University of Science and Technology (JUST) were selected for this prospective randomized, single blinded; split-mouth clinical trial. The teeth were randomly divided into 2 treatment groups: in the ZOE group (n=65 teeth) hemostasis was achieved by a dry cotton pellet, then the chamber was filled with zinc oxide eugenol (ZOE) directly over the pulp on one side. In the FS group (n=65 teeth) hemostasis was achieved by a wet cotton pellet, ferric sulphate (FS) was applied on the pulp, then the chamber was filled with (ZOE) on the contralateral side. All teeth were restored with prefabricated stainless steel crowns (SSC). Patients were recalled for evaluation clinically after 1month, then clinically and radiographically after 3, 6, 12 and 24 months. Two experienced and calibrated pediatric dentists who were not involved in the investigation blindly assessed the radiographs.

Study Design

Study Type:
Interventional
Actual Enrollment :
65 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Clinical Trial Comparing Reinforced Zinc Oxide Eugenol to Ferric Sulphate as a Pulpotomy Agent in Primary Teeth
Actual Study Start Date :
Jan 2, 2013
Actual Primary Completion Date :
Jan 2, 2014
Actual Study Completion Date :
Apr 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: ZOE group

Pulp hemostasis achieved by a dry cotton pellet applied on the pulp, then the chamber was filled with reinforced zinc oxide eugenol (ZOE) directly over the pulp.

Procedure: Pulp hemostasis with a dry cotton pellet
Application of a dry cotton pellet, then the chamber was filled with ZOE directly over the pulp

Procedure: Stainless steel crown
Stainless steel crown placed as a final restoration

Active Comparator: FS group

Pulp hemostasis achieved by a wet cotton pellet impregnated with ferric sulphate (FS) applied on the pulp, then the chamber was filled with (ZOE) directly over the pulp.

Procedure: Pulp hemostasis with a wet cotton pellet impregnated with FS
Application of a a wet cotton pellet impregnated with FS, then the chamber was filled with ZOE directly over the pulp

Procedure: Stainless steel crown
Stainless steel crown placed as a final restoration

Outcome Measures

Primary Outcome Measures

  1. Number of teeth which are asymptomatic without clinical signs of disease [24 months]

    including percussion sensitivity, spontaneous pain, mobility, or abscess (Clinical)

  2. Number of teeth with no pathological changes present [24 months]

    including radiolucency, root or bone resorption (Radiographic)

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy children

  • Child has cooperative behaviour in the dental chair

  • No history of spontaneous pain

  • Deep caries in the tooth

  • Carious exposure of a vital pulp

  • A restorable tooth after completion of the pulp treatment

  • Healthy periapical tissue on pre-operative periapical radiograph

Exclusion Criteria:
  • Presence of tenderness to percussion and/or mobility

  • Pathologic radiographic signs on pre-operative periapical radiograph including external or internal root resorption, calcification in the canal, periodontal membrane widening, periapical pathology, and furcation radiolucency.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jordan University of Science and Technology Irbid Jordan 22110

Sponsors and Collaborators

  • King Abdullah University Hospital
  • Jordan University of Science and Technology

Investigators

  • Principal Investigator: Ola B. Al-Batayneh, Jordan University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
King Abdullah University Hospital
ClinicalTrials.gov Identifier:
NCT05792748
Other Study ID Numbers:
  • 19/2013
First Posted:
Mar 31, 2023
Last Update Posted:
Mar 31, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by King Abdullah University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2023